相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Genevieve M. Gerhard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events
Ryosuke Matsukane et al.
SCIENTIFIC REPORTS (2021)
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Sijin Cheng et al.
CELL (2021)
Chemotherapy-associated steatohepatitis
Lucy Meunier et al.
ANNALS OF HEPATOLOGY (2020)
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neutrophils as emerging therapeutic targets
Tamas Nemeth et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
Samantha K. Greaney et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity
Alexander H. Morrison et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Durable and controlled depletion of neutrophils in mice
Gael Boivin et al.
NATURE COMMUNICATIONS (2020)
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity
Caroline Bonnans et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A conserved dendritic-cell regulatory program limits antitumour immunity
Barbara Maier et al.
NATURE (2020)
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Adrienne M. Luoma et al.
CELL (2020)
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice
Giada Ingoglia et al.
BLOOD ADVANCES (2020)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso et al.
CANCER CELL (2020)
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
Takaaki Oba et al.
NATURE COMMUNICATIONS (2020)
Neutrophil diversity and plasticity in tumour progression and therapy
Sebastien Jaillon et al.
NATURE REVIEWS CANCER (2020)
Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
Rapolas Zilionis et al.
IMMUNITY (2019)
Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data
Samuel L. Wolock et al.
CELL SYSTEMS (2019)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity
Mashito Sakai et al.
IMMUNITY (2019)
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2019)
The Gene Ontology Resource: 20 years and still GOing strong
S. Carbon et al.
NUCLEIC ACIDS RESEARCH (2019)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 119, 2017)
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2018)
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
Koji Haratani et al.
JAMA ONCOLOGY (2018)
RNA velocity of single cells
Gioele La Manno et al.
NATURE (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Neutrophils: New insights and open questions
Klaus Ley et al.
SCIENCE IMMUNOLOGY (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
SPRING: a kinetic interface for visualizing high dimensional single-cell expression data
Caleb Weinreb et al.
BIOINFORMATICS (2018)
SCANPY: large-scale single-cell gene expression data analysis
F. Alexander Wolf et al.
GENOME BIOLOGY (2018)
CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells
Xin Hou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Single-cell barcoding and sequencing using droplet microfluidics
Rapolas Zilionis et al.
NATURE PROTOCOLS (2017)
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
Sean P. Arlauckas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Identification of pro-inflammatory CD205+ macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B
Liang Yong et al.
SCIENTIFIC REPORTS (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
CSF-1R-Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy
Katelyn T. Byrne et al.
JOURNAL OF IMMUNOLOGY (2016)
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
Igor Theurl et al.
NATURE MEDICINE (2016)
Single Targeted Exon Mutation Creates a True Congenic Mouse for Competitive Hematopoietic Stem Cell Transplantation: The C57BL/6-CD45.1STEM Mouse
Francois E. Mercier et al.
STEM CELL REPORTS (2016)
The role of myeloid cells in cancer therapies
Camilla Engblom et al.
NATURE REVIEWS CANCER (2016)
Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells
Allon M. Klein et al.
CELL (2015)
Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
Peter Johnson et al.
CLINICAL CANCER RESEARCH (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2013)
Gene expression profiling of whole blood in ipilimumab-treated patients for identification of potential biomarkers of immune-related gastrointestinal adverse events
Vafa Shahabi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Qualimap: evaluating next-generation sequencing alignment data
Fernando Garcia-Alcalde et al.
BIOINFORMATICS (2012)
Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism
Jun-Xia Wang et al.
BLOOD (2012)
Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
Matthew M. Meredith et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Regulation of hepatocyte fate by interferon-γ
Christopher J. Horras et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection
Karen D. Carr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
分享论文
